SV Investment Corp is a Korea-based venture capital (VC) firm principally engaged in the investment in small to medium enterprises (SMEs). The Company principally engaged in the investment in SMEs and venture companies, overseas investment, establishment and management of business incubation centers, as well as formation of private equity funds (PEF). In addition, the Company also provides initial public offering (IPO), merger and acquisitions (M&A), and secondary support services.

Employees

Sector

Investment Management & Fund Operators

More about the company

Quotes

Date	Price	Change	Volume
26-08-27	₩2,515.00	+3.50%	13,456,563
26-08-26	₩2,430.00	-2.21%	2,117,646
26-08-25	₩2,485.00	-5.33%	7,659,650
26-08-24	₩2,625.00	+29.95%	1,064,028
26-08-21	₩2,020.00	-4.27%	456,037

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 2026-08-25			5-day change	1st Jan Change
2,485.00 ^KRW	-5.33%		+16.12%	+45.24%

08-19	KaliVir Immunotherapeutics, Inc. announced that it has received $25 million in funding from Premier Partners, LLC, Quad Investment Management Corp., Nextrans, Flexus Partners Co., Ltd., SV Investment Corporation, Company K Partners Limited	CI
07-02	LinqAlpha Inc. announced that it has received $21.99996 million in funding from a group of investors	CI

Market Cap	151B 109M 93.97M 87.98M 80.56M 152M 10.46B 152M 1.04B 407M 5.27B 411M 402M 17.44B	P/E 2025	-13.1x	P/E 2026	-205x
Enterprise Value	158B 115M 98.43M 92.15M 84.38M 159M 10.95B 159M 1.09B 427M 5.52B 431M 421M 18.27B	EV / Sales 2025	3.42x	EV / Sales 2026	9.89x
Free-Float	75.22%	Yield 2025 *	-	Yield 2026	-

08-19	KaliVir Immunotherapeutics, Inc. announced that it has received $25 million in funding from Premier Partners, LLC, Quad Investment Management Corp., Nextrans, Flexus Partners Co., Ltd., SV Investment Corporation, Company K Partners Limited	CI
07-02	LinqAlpha Inc. announced that it has received $21.99996 million in funding from a group of investors	CI
06-18	SV Investment Corporation Reports Earnings Results for the Full Year Ended March 31, 2026	CI
05-29	XCENA Inc. announced that it has received KRW 202 billion in funding from a group of investors	CI
05-27	ASTEROMORPH announced that it has received KRW 47 billion in funding from a group of investors	CI
05-20	LinqAlpha Inc. announced that it expects to receive $19.999992 million in funding	CI
05-13	SV Investment Corporation announces Annual dividend, payable on July 16, 2026	CI
04-13	XCENA Inc. announced that it expects to receive KRW 150 billion in funding from a group of investors	CI
02-25	GenEdit Inc. announced that it has received $60 million in funding from a group of investors	CI
02-13	SV Investment Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11-14	SV Investment Corporation Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
25-10-27	PineTree Therapeutics, Inc. announced that it has received $47.000004 million in funding from a group of investors	CI
25-08-21	PineTree Therapeutics, Inc. announced that it expects to receive $48.00006 million in funding	CI

1 day	-5.33%
1 week	+16.12%
Current month	+41.43%
1 month	+38.29%
3 months	-26.37%
6 months	-40.55%
Current year	+45.24%

SV Investment Corporation Stock

Stocks

A289080

KR7289080004

Investment Management & Fund Operators

Valuation : SV Investment Corporation

Chart: SV Investment Corporation

Latest news : SV Investment Corporation

Quotes and Performance

Price Extremes

Managers and Directors : SV Investment Corporation

Venture Capital

Financials

Company Profile

Quotes

1 week	2,000	2,625
1 month	1,439	2,625
Current year	1,439	5,030
1 year	1,439	5,030
3 years	1,156	5,030
5 years	1,156	5,030
10 years	1,156	8,570

Manager	Title	Age	Since
Won-Ho Hong CEO	Chief Executive Officer	61	2019-09-29
Seong-Ho Park CEO	Chief Executive Officer	57	-
Ji-Hwa Ryu PRN	Corporate Officer/Principal	56	2023-06-29

Director	Title	Age	Since
Seong-Ho Park BRD	Director/Board Member	57	-
Won-Ho Hong BRD	Director/Board Member	61	2019-09-29
Ji-Hwa Ryu BRD	Director/Board Member	56	2023-06-29

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SV INVESTMENT CORPORATION	-5.33%	+16.12%	+41.19%	+25.76%	105M
BB BIOTECH AG	+1.07%	+3.09%	+74.77%	+42.89%	3.85B
HERCULES CAPITAL, INC.	-0.68%	+2.88%	-9.69%	+6.63%	3.26B
HBM HEALTHCARE INVESTMENTS AG	+0.21%	-3.49%	+33.22%	+34.90%	1.93B
MOLTEN VENTURES PLC	+1.81%	+1.08%	+94.94%	+183.39%	1.49B
OCTOPUS APOLLO VCT PLC	0.00%	0.00%	-1.72%	-7.02%	732M
MIRAE ASSET VENTURE INVESTMENT CO., LTD.	+1.76%	+0.19%	+163.19%	+239.85%	592M
BRITISH SMALLER COMPANIES VCT PLC	0.00%	0.00%	-3.33%	-7.05%	411M
OCTOPUS TITAN VCT PLC	0.00%	0.00%	-40.68%	-75.18%	392M
PEMBROKE VCT PLC	0.00%	0.00%	-0.53%	-13.02%	372M
Average	-0.12%	+2.59%	+35.14%	+43.12%	1.31B
Weighted average by Cap.	+0.42%	+0.97%	+41.41%	+47.92%

	2025	2026
Net sales	19.98B 14.46M 12.42M 11.62M 10.64M 20.05M 1.38B 20.11M 138M 53.81M 696M 54.31M 53.13M 2.3B	20.52B 14.85M 12.75M 11.93M 10.93M 20.59M 1.42B 20.64M 141M 55.24M 715M 55.75M 54.55M 2.37B
Net income	-5.23B -3.79M -3.25M -3.04M -2.79M -5.25M -362M -5.26M -36.04M -14.09M -182M -14.22M -13.91M -603M	-1B -725K -622K -582K -533K -1M -69.21M -1.01M -6.9M -2.7M -34.88M -2.72M -2.66M -115M
Net Debt	-1.04B -753K -647K -605K -554K -1.04M -71.95M -1.05M -7.17M -2.8M -36.26M -2.83M -2.77M -120M	7.18B 5.2M 4.46M 4.18M 3.82M 7.2M 496M 7.22M 49.45M 19.33M 250M 19.51M 19.09M 828M